Patient Attitudes Toward Ultrasound Measurement of Cervical Length - Full Text View

Purpose

The investigators propose a prospective evaluation of methods to assess cervical length for uncomplicated singleton gestations between 18-28 weeks presenting to the MFM office for routine mid pregnancy ultrasound. The investigators hypothesize that a sequential approach to screening of the cervix (which consists of initial transabdominal evaluation first with transvaginal ultrasound reserved only for those patients in whom the cervix appears short on transabdominal exam or when adequate views cannot be obtained with the transabdominal approach alone) will take less time, will result in the same number of adequate views of the cervix and will have higher patient satisfaction that a universal transvaginal screening approach.

OBJECTIVE

To determine the best strategy for cervical length screening in uncomplicated singleton gestations between the gestational ages of 18-28 weeks.

Primary outcome:

1) Time required to obtain adequate views of the cervical length.

Secondary outcomes:

Patient satisfaction with ultrasound experience as measured by patient questionnaire
Number of adequate views of the cervix obtained with each approach

STUDY DESIGN

This is a prospective study to compare strategies for cervical length measurements in uncomplicated singleton gestations seen in the MFM office for routine mid pregnancy fetal well being ultrasound between 18-28 weeks gestation. The different strategies include 1) Transabdominal assessment of the cervix (current standard), 2) Sequential evaluation of the cervical length (transabdominal followed by transvaginal if necessary due to short cervix or inadequate transabdominal views), and 3) Transvaginal cervical length assessment. Patients with an uncomplicated singleton gestation presenting for a routine mid pregnancy ultrasound between 18-28 weeks will be randomized into one of the three groups noted above after consent is obtained. Ultrasound examination will then take place and data collected. The various strategies listed above will be compared for the following:

Time required to obtain views of the cervix
1. Time from initiation of exam to completion of cervical assessment
2. Time for completion of entire exam
Patient satisfaction
1. Comfort/Discomfort of exam procedure
2. Overall impression of exam process
Number of adequate views of the cervix obtained

Maternal demographics including age, parity, weight, height and due date/gestational age will also be obtained for all consenting patients.

Condition	Intervention
Cervical Insufficiency	Procedure: Sequential ultrasound Procedure: Transvaginal ultrasound

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Screening
Official Title:	Patient Attitudes Regarding Abdominal Versus Transvaginal Ultrasonography for Assessment of the Cervical Length in Low Risk Patients: a Randomized Trial

Further study details as provided by Intermountain Women and Children's Research:

Primary Outcome Measures:

Time [ Time Frame: Assessed on the day of ultrasound (one single visit) ] [ Designated as safety issue: No ]
The time it takes to perform the assessment of the cervix will be recorded, as well as the time it takes to perform the entire exam.

Secondary Outcome Measures:

Patient satisfaction [ Time Frame: Assessed the day of the ultrasound (one single visit) ] [ Designated as safety issue: No ]
Participants will complete a survey indicating their opinions about the ultrasound experience.
Ultrasound adequacy [ Time Frame: Assessed on the day of the ultrasound (one single visit) ] [ Designated as safety issue: No ]
Assess the frequency with which adequate views of the cervix can be obtained using transabdominal vs transvaginal ultrasonography

Estimated Enrollment:	210
Study Start Date:	November 2011
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
No Intervention: Standard Ultrasound Current standard of care - one abdominal view of the cervix to rule out placenta previa
Experimental: Sequential Screen Start with 3 abdominal views of the cervix with measurement. If 3 adequate views cannot be obtained, or if measurement is less than 3cm, then will perform transvaginal scan for measurement.	Procedure: Sequential ultrasound Abdominal ultrasound first; obtain 3 adequate measurements. If 3 adequate views not obtained or if measurement less than 3 cm, perform transvaginal ultrasound for measurement.
Experimental: Screening Transvaginal Ultrasound Obtain 3 adequate cervical length measurements using transvaginal ultrasound	Procedure: Transvaginal ultrasound Obtain 3 transvaginal ultrasound cervical length measurements

Detailed Description:

BACKGROUND AND SIGNIFICANCE

Preterm birth is a significant problem in the United States and worldwide. Approximately twelve percent of births in the US occur before 37 weeks and are considered preterm. Of these, 80% are considered "spontaneous preterm deliveries" (as opposed to iatrogenic) and are related to preterm labor or preterm rupture of membranes (Arias, 2003). Certain pregnancy characteristics have been identified to determine those patients at risk for preterm delivery. These include a history of preterm birth (Esplin, 2008), uterine anomalies, multiple gestation, among other things, both modifiable and not (Gardosi, 2000; Ananth, 2006). However, an important risk factor that can be identified is the presence of specific changes in the cervix, such as cervical shortening, and in fact, studies indicate that the risk of spontaneous preterm birth increases as cervical length decreases (Iams, 1996; Hibbard, 2000).

Some authors now advocate the universal screening of all pregnant women for cervical shortening at the time of the ultrasound that is performed at 18-28 weeks in most women. However, the best approach to evaluate the cervix in low risk patients (those without an identifiable risk factor) remains controversial.

PROTOCOL

Patients will be identified in the Maternal Fetal Medicine office and consented for randomization at the time of presentation for previously scheduled mid-trimester ultrasound
Patients will be given randomly generated treatment allocations within sealed opaque envelopes. Once a patient has consented to enter the trial, the envelope will be opened by the ultrasonographer to determine the assigned treatment regimen.
Patients will be randomized into one of three groups:
1. Standard US evaluation
2. Sequential US evaluation
3. Transvaginal cervical length screening
Maternal demographics including maternal age, height, weight, parity, and gestational age will be collected from the patient as part of the patient questionnaire. Ultrasound exam data including measurements of the fetal biometry, presence of fetal anomalies, placental location and amniotic fluid volume will be collected from the official ultrasound report.
1. Patients will be assigned a unique study ID number at the time of enrollment and all information including time of ultrasound procedures, clinical data and adequacy of cervical measurement will be linked by the ID number
2. All data will be entered into an electronic data base in a de-identified fashion and kept in a secure, encrypted web-based database management program (RedCap).

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

singleton gestation
between 18-28 weeks

Exclusion Criteria:

presence of cerclage
known short cervix
prior preterm birth

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01482039

Contacts

Contact: Stephanie T Romero, MD

828-301-2711

stephanie.romero@hsc.utah.edu

Locations

United States, Utah
Intermountain Medical Center	Recruiting
Salt Lake City, Utah, United States, 84177
Contact: Stephanie T Romero, MD 828-301-2711 stephanie.romero@hsc.utah.edu
Principal Investigator: Stephanie T Romero, MD
Sub-Investigator: Michael S Esplin, MD
Sub-Investigator: Calla Holmgren, MD

Sponsors and Collaborators

Intermountain Women and Children's Research

Investigators

Principal Investigator:

Stephanie T Romero, MD

Intermountain Medical Center

More Information

Publications:

Esplin MS, O'Brien E, Fraser A, Kerber RA, Clark E, Simonsen SE, Holmgren C, Mineau GP, Varner MW. Estimating recurrence of spontaneous preterm delivery. Obstet Gynecol. 2008 Sep;112(3):516-23.

Adams MM, Elam-Evans LD, Wilson HG, Gilbertz DA. Rates of and factors associated with recurrence of preterm delivery. JAMA. 2000 Mar 22-29;283(12):1591-6.

Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996 Feb 29;334(9):567-72.

Hibbard JU, Tart M, Moawad AH. Cervical length at 16-22 weeks' gestation and risk for preterm delivery. Obstet Gynecol. 2000 Dec;96(6):972-8.

Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, Vijayaraghavan J, Trivedi Y, Soma-Pillay P, Sambarey P, Dayal A, Potapov V, O'brien J, Astakhov V, Yuzko O, Kinzler W, Dattel B, Sehdev H, Mazheika L, Manchulenko D, Gervasi MT, Sullivan L, Conde-Agudelo A, Phillips JA, Creasy GW; for the PREGNANT Trial. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011 Jul;38(1):18-31. Epub 2011 Jun 15.

Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007 Aug 2;357(5):462-9.

Stone PR, Chan EH, McCowan LM, Taylor RS, Mitchell JM; SCOPE Consortium. Transabdominal scanning of the cervix at the 20-week morphology scan: comparison with transvaginal cervical measurements in a healthy nulliparous population. Aust N Z J Obstet Gynaecol. 2010 Dec;50(6):523-7. Epub 2010 Sep 16.

Responsible Party:	Stephanie T. Romero, Principal Investigator, Intermountain Women and Children's Research
ClinicalTrials.gov Identifier:	NCT01482039 History of Changes
Other Study ID Numbers:	Sonographic Cervical Length
Study First Received:	November 25, 2011
Last Updated:	November 28, 2011
Health Authority:	United States: Institutional Review Board

Keywords provided by Intermountain Women and Children's Research:

short cervix
cervical shortening
preterm birth

ClinicalTrials.gov processed this record on June 18, 2013

Patient Attitudes Toward Ultrasound Measurement of Cervical Length (TVUS)